Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.73

+0.50 (0.82%)

as of Aug 14, 2026, 8:00:00 pm Market Open.

1631 watching

Investor Insights

Aug 15, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixed but generally positive outlook from a variety of analysts. The company has shown solid growth, particularly in Asia, where it is capitalizing on opportunities in wealth management and life insurance. Despite recent reports suggesting higher valuations, some experts caution that the current price might be overbought, and they advise being selective in the financials sector. Analysts note that while MFC faces challenges from a new tax in China and a dip in US operations, its robust dividend yield and consistent performance make it a reliable long-term hold. Overall, many recommend waiting for potential pullbacks before increasing positions, highlighting MFC's potential for sustained growth amidst the competitive landscape of Canadian financials.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

COMMENT

This is a good entry point for someone with a 2-year outlook. Has a lot of sensitivity to the marketplace and interest rates. New management has worked to hedge this more. Doesn't expect they will have a very good quarter and continued market volatility will impact the earnings.

DON'T BUY

Not a fan. Doesn't like the US operations, which hurt them very badly in the last downturn. There huge acquisition of John Hancock hasn't really worked out that well. Still likes their Far East prospects and their Canadian operations.

WATCH

Was probably the most leveraged company to the stock and bond market coming of 2008. Have done an incredibly good job of de-leveraging in the last two years. Sees some decent upside potential. He has a $19 target, but is a little nervous on this given where interest rates and where the stock market has gone. $19 would be 18-24 months. Next quarter could be a little dicey for them.

BUY

Playing a dangerous game if it is just for the next quarter or two. Tremendous franchise. De-risked balance sheet dramatically. It is one of his largest holdings in that sector.

BUY

Doesn’t expect a dividend increase any time soon. Struggling through their problems with their GIC portfolios that are levered to equity markets and interest rates. Believes interest rates are going up, which is good for lifecos and over time he thinks equity markets will rise.

BUY

Good international exposure. Likes their insurance exposure in Asia. Good dividend. Did a good job of restructuring. It will benefit if interest rates go up. Good entry point.

BUY

Sees good upside from here. Hedged some of the risks to the stock market, but not all of them.

BUY

He has a model price of $22.67. A positive differential of 35%. Speculative but would recommend a 2%-3% holding in your portfolio.

BUY

Good long-term investment. Ran their equity portfolio/fixed income business unhedged for many, many years. New management is moving to a more hedged position so they can generate more money from the business rather than being subject to the vagaries of the market. Asian exposure is becoming a more important part of the business. 3% yield.

COMMENT

Fundamentally it is one of the few insurance companies with such a vast capital structure. There needs to be some way to go up from here given the cost of capital. Reported some gains in the short book, which was not noticed by the market.

DON'T BUY

If you make the case that Asia becomes very big to them then you buy the stock. He doesn’t own it because the sector is out of favour. From a timing standpoint you are challenged. With low interest rates it impacts their ability to make money. Some of the products they had growth in have not been as profitable as they would have liked. He would prefer something that would really jump when the market gets moving.

COMMENT

Had a hard look at this one at a lower price but didn't buy because he was worried about transparency on their US liabilities. He would want to see another quarter or two before making a decision. Prefers banks.

TOP PICK

Their Asian business is a gem and they are not getting full credit for it. This part is larger than their Canadian operations if you include Japan. They're adjusting the problems were people felt they had too much exposure to the stock market.

DON'T BUY

Having a great day today because the markets are up a lot but unfortunately this has become a pretty high beta stock. Believes we will continue to see downside pressure on yields in the US, which is not good for this company.

PAST TOP PICK

(A Top Pick June 30/10. Up 6.86%.) Still likes. Less sensitive to changes in the capital markets. Likes what management is doing.

Showing 1,291 to 1,305 of 2,284 entries

Most Recent Experts

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Richard Orrell

RN Croft Financial Group

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)